Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Analog 23 is a promising compound for prostate cancer treatment.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Androgen use may increase the risk of stroke, but more research is needed.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone helps human pancreatic cells increase insulin release.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.